Variant report
Variant | esv3428770 |
---|---|
Chromosome Location | chr2:77438744-77440792 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:77426705..77429673-chr2:77438282..77439862,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551030939 | chr2:77438763-77438764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528557480 | chr2:77438784-77438785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546693839 | chr2:77438817-77438818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138042517 | chr2:77438903-77438904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564352467 | chr2:77438939-77438940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140190773 | chr2:77439014-77439015 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533320239 | chr2:77439038-77439039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547318790 | chr2:77439053-77439054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567045208 | chr2:77439065-77439066 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181212024 | chr2:77439103-77439104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185753364 | chr2:77439126-77439127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190555282 | chr2:77439201-77439202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183177466 | chr2:77439206-77439207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539265845 | chr2:77439207-77439208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557886901 | chr2:77439217-77439218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572870371 | chr2:77439219-77439220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533849099 | chr2:77439220-77439221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189160998 | chr2:77439288-77439289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573656133 | chr2:77439302-77439303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190760187 | chr2:77439305-77439306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577604316 | chr2:77439322-77439323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376832900 | chr2:77439338-77439339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530137946 | chr2:77439345-77439346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548532983 | chr2:77439398-77439399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34171956 | chr2:77439399-77439400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs67341069 | chr2:77439400-77439401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563982615 | chr2:77439446-77439447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72016173 | chr2:77439482-77439483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs67657668 | chr2:77439493-77439494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575849670 | chr2:77439549-77439550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546105617 | chr2:77439553-77439554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367948629 | chr2:77439583-77439584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576390780 | chr2:77439584-77439585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564669048 | chr2:77439594-77439595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527960619 | chr2:77439596-77439597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71420992 | chr2:77439598-77439599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183001767 | chr2:77439599-77439600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11126594 | chr2:77439600-77439601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35907246 | chr2:77439601-77439602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1176790 | chr2:77439602-77439603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529240030 | chr2:77439604-77439605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11884088 | chr2:77439621-77439622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532562011 | chr2:77439622-77439623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550116327 | chr2:77439626-77439627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568814806 | chr2:77439637-77439638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12615140 | chr2:77439638-77439639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371941369 | chr2:77439676-77439677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149487043 | chr2:77439677-77439678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187617162 | chr2:77439700-77439701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11894888 | chr2:77439702-77439703 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77436600-77439000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:77437800-77439200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:77438200-77438800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr2:77438200-77439000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr2:77438600-77438800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr2:77438800-77440200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr2:77439000-77440000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:77439200-77441200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr2:77440000-77441600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr2:77440200-77440600 | Enhancers | Pancreatic Islets | Pancreatic Islet |